drug

CTX-10726

1 story · latest Aug 6, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Compass Therapeutics

Timeline

Compass Therapeutics awaits FDA input on tovecimig biliary cancer data

Aug 6Quarterly updateCompass Therapeutics

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.